Shots:

• Medtronic acquires Avenu Medical for its Percutaneous Fistula Creation Technology that will foster Medtronic’s peripheral vascular access portfolio and improves outcomes for patients with ESRD undergoing dialysis. The acquisition is expected to close in Oct’2020
• The acquisition allows Medtronic to bring less invasive- endovascular solutions to patients requiring durable vascular access. This marks the sixth acquisitions that Medtronic has made in 2020
• Avenu Medical's Ellipsys Vascular Access system is a single-catheter- ultrasound-guided device that inserts a catheter percutaneously into the arm to create a durable AV fistula and has received CE Mark in the EU & is the US FDA approved

­ Ref: Medtronic | Image: Avenu Medical